Empaveli 1080 MG
Ended Awarded
- Contract number
- 36C24525N0408
- Awardee
-
APL Sales I LLC UEI XXKJSCZRL266
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $26,219
Award facts
- Contract value 100% obligated
- $26,218.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to APL Sales I LLC, a subsidiary of Apellis Pharmaceuticals, Inc. The contract is for the delivery of EMPAVELI 1080 MG, a complement C3 inhibitor used to treat paroxysmal nocturnal hemoglobinuria, a rare blood disorder. The contract has a ceiling value of $26,218.96 and a completion date of February 27, 2025.
The contract was awarded under the VA's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which is a multiple-award contract. APL Sales I LLC also holds a Blanket Purchase Agreement (BPA) with the VA with a $2 million ceiling value through March 2025. These contract vehicles allow the VA to streamline the procurement of critical pharmaceutical products, such as EMPAVELI, to support veterans' healthcare needs. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 36C24525N0408?
36C24525N0408 was awarded to APL Sales I LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on February 25, 2025.
How much is contract 36C24525N0408 worth?
The government has obligated $26,219 on 36C24525N0408.
Is contract 36C24525N0408 an order under another contract?
Yes. 36C24525N0408 is a delivery order under 36F79722D0039, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0408 competed?
The extent of competition for 36C24525N0408 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award